Article
Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma.
Molecular carcinogenesis - 1 Jul 2012
Yang Yuan, Zhou Yun, Lu Ming, An Yu, Li Rui, Chen Yao, Lu Da-Ru, Jin Li, Zhou Wei-Ping, Qian Ji, Wang Hong-Yang
Abstract excerpt
Human fibroblast growth factor receptor 4 (FGFR4) polymorphisms have recently been shown to be associated with tumor progression of various types of cancer, including cancer of the breast, colon, and prostate and sarcoma. However, their association with hepatocellular carcinoma (HCC) is unknown. We evaluated the association of FGFR4 polymorphisms with risk of HCC in a study population with HCC and with/without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
